# MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)

> **NCT04367077** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Healios K.K.** · enrollment: 400 (estimated)

## Conditions studied

- ARDS

## Interventions

- **BIOLOGICAL:** MultiStem
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04367077
- **Lead sponsor:** Healios K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-28
- **Primary completion:** 2023-01
- **Final completion:** 2023-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2021-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04367077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04367077, "MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04367077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*